Company Monitoring Page for Anacor

latest headlines for company on cafepharma

2016 went out like a lamb in the biopharma M&A world. Will it roar back in 2017? Plus, top 10 deals
Endpoints
Wed, 02/22/17 - 11:43 am
Tags:
M&A, Shire, Baxalta, Pfizer, Medivation, Mylan, Meda, AbbVie, Stemcentrx, Anacor
Why Pfizer's Acquisition of Anacor Is a Great Fit
Motley Fool
Thu, 08/18/16 - 04:48 pm
Tags:
Pfizer, M&A, Anacor
Recent Corporate and Pipeline Developments for Pfizer
Market Realist
Mon, 08/15/16 - 11:07 am
Tags:
Pfizer, M&A, Bamboo Therapeutics, Anacor, Western Oncolytics, avelumab, Xeljanz, bococizumab, ertugliflozin, utomilumab
What Can We Expect from the Pfizer-Anacor Deal?
Market Realist
Thu, 07/7/16 - 09:23 am
Tags:
Pfizer, Anacor, M&A
Biotech: What's Ahead For The Second Half Of 2016
Seeking Alpha
Tue, 07/5/16 - 09:57 am
Tags:
biotech, AbbVie, Amgen, Allergan, Anacor, Gilead Sciences, Medivation, Pfizer, Sanofi
Pfizer Completes Acquisition of Anacor
Yahoo
Fri, 06/24/16 - 10:48 am
Tags:
Pfizer, Anacor, M&A
Next-generation eczema drugs on pace for 2017 launch
BioPharma Dive
Wed, 06/1/16 - 09:41 pm
Tags:
eczema, drug launches, Anacor, Regeneron, Sanofi
Anacor received rival bid before Pfizer deal - filing
Yahoo/Reuters
Thu, 05/26/16 - 07:40 pm
Tags:
Anacor, Pfizer, M&A
Pfizer's Big Bet on Eczema With Anacor Acquisition
Investopedia
Tue, 05/24/16 - 10:04 am
Tags:
Pfizer, Anacor, M&A, eczema, crisaborole
What Pfizer's Anacor Deal May Mean For It And For Regeneron
Seeking Alpha
Mon, 05/16/16 - 09:39 pm
Tags:
Pfizer, Anacor, Regeneron, M&A
4 things to know about Pfizer’s $5.2 billion acquisition target, Anacor
Marketwatch
Mon, 05/16/16 - 03:45 pm
Tags:
Pfizer, Anacor, M&A, crisaborole, eczema
Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel
Reuters
Mon, 05/16/16 - 10:39 am
Tags:
Pfizer, M&A, Anacor, eczema, crisaborole
2 Biotech Companies That Could Profit if Their Skin Treatments Are Successful
TheStreet.com
Tue, 04/5/16 - 10:06 pm
Tags:
Regeneron, dupilumab, Anacor, Crisaborole Topical Ointment, psoriasis, eczema
The Top 5 Best Performing Biotech Stocks of 2015
Motley Fool
Sat, 01/2/16 - 10:27 am
Tags:
biotech, Eagle Pharmaceuticals, Exelixis, Prothena, Anacor, Heron Therapeutics
3 Rising Biotechs That Should Continue Their Upward Trends
TheStreet.com
Sat, 12/12/15 - 01:58 pm
Tags:
biotech, Intra-Cellular Therapies, Anacor, Prothena
10 Best Nasdaq Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:49 pm
Tags:
Incyte, Myriad, Cara Therapeutics, Sucampo, ZS Pharma, Concert Pharmaceuticals, The Medicines Company, Lexicon Pharmaceuticals, Exelixis, Anacor
Anacor Shares Surge To All-Time Highs After Phase 3 Trials Of Eczema Drug
Yahoo/Benzinga
Mon, 07/13/15 - 07:32 pm
Tags:
Anacor, clinical trials, eczema, crisaborole, atopic dermatitis
The Hottest Question in Pharma: Which Company Will Be Next To Sell?
WSJ Pharmalot
Tue, 03/17/15 - 10:19 am
Tags:
M&A, Jazz Pharmaceuticals, Anacor, Perrigo Company, Kythera Biopharmaceuticals, Akorn, Impax Laboratories
Monday’s Top Biotech Stories: Allergan, Anacor, and Sinovac Biotech
Motley Fool
Mon, 07/21/14 - 10:43 am
Tags:
Allergan, layoffs, Anacor, Sinovac Biotech, Kerydin, earnings, China, Sandoz, vaccines
This Week in Biotech: Anacor's FDA A-OK and AbbVie's Insatiable Urge to Buy Something
Motley Fool
Mon, 07/14/14 - 09:33 am
Tags:
FDA, Anacor, Shire, M&A, AbbVie, Kerydin, Onychomycosis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.